Literature DB >> 25056401

Obesity and sleepiness in women with fibromyalgia.

Tânia Aparecida de Araújo1, Maria Carliana Mota, Cibele Aparecida Crispim.   

Abstract

Fibromyalgia (FM) is associated with a number of comorbidities, including chronic widespread pain, fatigue and non-restorative sleep. Evidence has shown that FM is closely associated with overweight and obesity. The objective of the present study was to investigate the relationship between obesity and sleepiness in women with FM. A total of 100 adult female patients with a prior medical diagnosis of FM participated in the study. Body mass, height and waist circumference were measured, and body mass index (BMI) was calculated. The diet quality was evaluated by the Healthy Eating Index. Subjective analyses of daytime sleepiness [Epworth Sleepiness Scale (ESS)] and sleep quality (Pittsburgh Sleep Quality) were performed. An obesity rate of 41 % was found in all women (56.1 % were sleepy and 43.9 % were not, p = 0.04). Obese women showed a greater level of sleepiness when compared with non-obese (10.2 and 7.0, respectively, p = 0.004). Sleepy women showed a greater weight gain after the diagnosis of FM when compared with non-sleepy women (11.7 and 6.4 kg, respectively, p = 0.04). A positive and significant correlation between BMI and sleepiness (r = 0.35, p = 0.02) was also found. In multivariate logistic regression, moderate or severe sleepiness (ESS >12) was associated with obesity (odds ratio 3.44, 95 % CI 1.31-9.01, p = 0.04). These results demonstrate an important association between sleepiness and FM, suggesting that the occurrence of obesity may be involved with sleepiness in these patients.

Entities:  

Mesh:

Year:  2014        PMID: 25056401     DOI: 10.1007/s00296-014-3091-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

2.  Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.

Authors:  Harvey Moldofsky; Herbert W Harris; W Tad Archambault; Terence Kwong; Seth Lederman
Journal:  J Rheumatol       Date:  2011-09-01       Impact factor: 4.666

Review 3.  Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea--a review.

Authors:  Lori A Panossian; Sigrid C Veasey
Journal:  Sleep       Date:  2012-05-01       Impact factor: 5.849

4.  Relationship between body mass index and fibromyalgia features.

Authors:  Muhammad B Yunus; Sule Arslan; Jean C Aldag
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

5.  Hypersomnolence in fibromyalgia syndrome.

Authors:  P Sarzi-Puttini; M Rizzi; A Andreoli; B Panni; M Pecis; S Colombo; M Turiel; M Carrabba; M Sergi
Journal:  Clin Exp Rheumatol       Date:  2002 Jan-Feb       Impact factor: 4.473

6.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Portuguese-language version of the Epworth sleepiness scale: validation for use in Brazil.

Authors:  Alessandra Naimaier Bertolazi; Simone Chaves Fagondes; Leonardo Santos Hoff; Vinícius Dallagasperina Pedro; Sérgio Saldanha Menna Barreto; Murray W Johns
Journal:  J Bras Pneumol       Date:  2009-09       Impact factor: 2.624

9.  Sleep stage dynamics in fibromyalgia patients and controls.

Authors:  Joseph W Burns; Leslie J Crofford; Ronald D Chervin
Journal:  Sleep Med       Date:  2008-03-07       Impact factor: 3.492

10.  Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index.

Authors:  Shahrad Taheri; Ling Lin; Diane Austin; Terry Young; Emmanuel Mignot
Journal:  PLoS Med       Date:  2004-12-07       Impact factor: 11.069

View more
  7 in total

1.  Obesity Moderates the Effects of Motivational Interviewing Treatment Outcomes in Fibromyalgia.

Authors:  Anthony S Kaleth; James E Slaven; Dennis C Ang
Journal:  Clin J Pain       Date:  2018-01       Impact factor: 3.442

Review 2.  Physiological Changes and Pathological Pain Associated with Sedentary Lifestyle-Induced Body Systems Fat Accumulation and Their Modulation by Physical Exercise.

Authors:  Enrique Verdú; Judit Homs; Pere Boadas-Vaello
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

Review 3.  The association between chronic pain and obesity.

Authors:  Akiko Okifuji; Bradford D Hare
Journal:  J Pain Res       Date:  2015-07-14       Impact factor: 3.133

4.  Association between Free Sugars Intake and Excessive Daytime Sleepiness among Chinese Adolescents.

Authors:  Yue Xi; Qian Lin; Qiping Yang; Fang Li; Hanmei Liu; Jing Luo; Yufeng Ouyang; Minghui Sun; Cuiting Yong; Caihong Xiang; Wenya Zheng
Journal:  Nutrients       Date:  2021-11-05       Impact factor: 5.717

5.  Fascial preadipocytes: another missing piece of the puzzle to understand fibromyalgia?

Authors:  Bruno Bordoni; Fabiola Marelli; Bruno Morabito; Francesca Cavallaro; David Lintonbon
Journal:  Open Access Rheumatol       Date:  2018-05-01

6.  The relationship between body mass index and pain, disease activity, depression and anxiety in women with fibromyalgia.

Authors:  Burhan Fatih Koçyiğit; Ramazan Azim Okyay
Journal:  PeerJ       Date:  2018-05-28       Impact factor: 2.984

7.  Dynamic Thiol/Disulphide Homeostasis in Patients With Fibromyalgia.

Authors:  Fatma Fidan; Berat Meryem Alkan; Fatma Gülçin Uğurlu; Sinem Bozkurt; Nebahat Sezer; Cemile Biçer; Özcan Erel; Özge Ardiçoğlu; Selami Akkuş
Journal:  Arch Rheumatol       Date:  2017-01-18       Impact factor: 1.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.